SCHEMBL7392020

SCHEMBL7392020

CC[C](C1CCCCC1)C1CCCCC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CES2 O00748 1/20 0.41
CES1 P23141 1/20 0.41
HSD11B1 P28845 1/20 0.38
NAAA Q02083 1/20 0.36
SHBG P04278 1/20 0.36
MGLL Q99685 1/20 0.36
ALDH1A1 P00352 3/20 0.35
HDAC8 Q9BY41 1/20 0.35
HDAC6 Q9UBN7 1/20 0.35
CYP1A2 P05177 1/20 0.35
TSHR P16473 3/20 0.33
EPHX1 P07099 1/20 0.33
NOS2 P35228 1/20 0.33
RECQL P46063 1/20 0.33
L3MBTL1 Q9Y468 1/20 0.32
SMN1; SMN2 Q16637 1/20 0.32
HSD17B10 Q99714 1/20 0.32
CA1 P00915 1/20 0.32
CA2 P00918 1/20 0.32
CA4 P22748 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990405 1.00 CES2 (0.41) CES2CES1HSD11B1NAAASHBG
SCHEMBL6990609 1.00 CES2 (0.41) CES2CES1HSD11B1NAAASHBG
SCHEMBL5720720 1.00 CES2 (0.41) CES2CES1HSD11B1NAAASHBG
SCHEMBL27992189 0.91 NOS2 (0.35) CES2CES1HSD11B1NOS2RECQL
SCHEMBL6989750 0.91 NOS2 (0.35) CES2CES1HSD11B1NOS2RECQL
SCHEMBL8626702 0.87
SCHEMBL8324332 0.86 TSHR (0.38) CES2CES1HSD11B1NAAATSHR
SCHEMBL29164029 0.78 NAAA (0.38) CES2CES1HSD11B1NAAASHBG
SCHEMBL5400951 0.77 CES2 (0.41) CES2CES1HSD11B1NAAASHBG
SCHEMBL435072 0.74 CES2 (0.39) CES2CES1HSD11B1NAAASHBG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-85104453-A Prepare a kind of method that is used for the treatment of the tetrahydro naphthols of hypertension 1986-12-10 CN claimed
CN-103391947-B Stabilization of polymers containing hydrolyzable functional groups 株式会社普利司通 2016-08-24 CN disclosed
US-6492397-B1 SUCH AS 1-PROPYL-4-BUTYL-1,3-DIHYDRO-3-((5-(2-(1H-TETRAZOL-5-YL)PHENYL)-2 -PYRIDINYL)METHYL)-2H-IMIDAZOL-2-ONE; ANGIO-TENSIN II ANTAGONISTS; CIRCULATORY DISORDERS; HYPERTENSION, CONGESTIVE HEART FAILURE PHARMACIA CORPORATION 2002-12-10 US disclosed
US-5795905-A 3-AMINO-5-PHENYL-1,2,4-TRIAZOLES NEUROCRINE BIOSCIENCES, INC. (US) 1998-08-18 US disclosed
EP-0846108-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1998-06-10 EP disclosed
US-5693619-A ENZYME INHIBITORS; ADMINISTERED TO TREAT CONGESTIVE HEART FAILURE AND HYPERTENSION BOEHRINGER INGELHEIM (CANADA), LTD. (CA) 1997-12-02 US disclosed
EP-0589445-B1 Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives BIO MEGA BOEHRINGER INGELHEIM (CA) 1997-01-15 EP disclosed
WO-1996039400-A1 AMINO-SUBSTITUTED THIADIAZOLES, PYRIMIDINES, TRIAZINES OR TRIAZOLES USEFUL AS CTF RECEPTOR ANTAGONISTS NEUROCRINE BIOSCIENCES, INC. (US) 1996-12-12 WO disclosed
US-5541163-A HYPOTENSIVE AGENTS BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1996-07-30 US disclosed
EP-0703505-A1 Toner for two-component type developer MITA INDUSTRIAL CO., LTD. (JP) 1996-03-27 EP disclosed
EP-0589445-A1 Renin Inhibiting N-(2-Amino-2-oxoethyl)Butanediamide Derivatives BIO-MEGA/BOEHRINGER INGELHEIM RESEARCH INC. (CA) 1994-03-30 EP disclosed
CN-85104453-A Prepare a kind of method that is used for the treatment of the tetrahydro naphthols of hypertension 1986-12-10 CN disclosed